X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3122) 3122
Book Review (885) 885
Publication (399) 399
Book / eBook (183) 183
Book Chapter (55) 55
Conference Proceeding (18) 18
Reference (5) 5
Dissertation (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2895) 2895
animals (2228) 2228
humans (1539) 1539
male (828) 828
neurosciences (818) 818
mice (790) 790
rats (683) 683
female (551) 551
endocrinology & metabolism (487) 487
biochemistry & molecular biology (475) 475
receptors (455) 455
vasoactive-intestinal-peptide (431) 431
physiology (430) 430
gene expression (410) 410
cell biology (408) 408
cyclase-activating polypeptide (391) 391
physiological aspects (378) 378
research (373) 373
pituitary adenylate cyclase-activating polypeptide (349) 349
expression (336) 336
rodents (333) 333
molecular sequence data (332) 332
signal transduction (332) 332
neurons (330) 330
pharmacology & pharmacy (320) 320
pacap (309) 309
neuropeptides (308) 308
rna, messenger - metabolism (302) 302
peptides (297) 297
receptor (291) 291
proteins (284) 284
vasoactive intestinal polypeptide (284) 284
amino acid sequence (272) 272
cells, cultured (272) 272
immunohistochemistry (267) 267
multidisciplinary sciences (266) 266
vip (266) 266
mice, inbred c57bl (254) 254
messenger-rna (247) 247
brain (245) 245
analysis (243) 243
vasoactive intestinal peptide - metabolism (242) 242
article (237) 237
neurology (237) 237
mice, knockout (232) 232
vasoactive intestinal peptide - pharmacology (231) 231
gene-expression (229) 229
rna, messenger - genetics (229) 229
cells (222) 222
nervous system (220) 220
biomedicine (219) 219
medicine (206) 206
receptors, pituitary adenylate cyclase-activating polypeptide (203) 203
vasoactive intestinal peptide (200) 200
abridged index medicus (196) 196
reverse transcriptase polymerase chain reaction (196) 196
rats, sprague-dawley (195) 195
hormones, hormone substitutes, and hormone antagonists (194) 194
receptors, vasoactive intestinal peptide - genetics (192) 192
immunology (189) 189
in-vitro (187) 187
base sequence (178) 178
research article (177) 177
adenylate-cyclase (175) 175
inflammation (174) 174
genetic aspects (173) 173
neurons - metabolism (170) 170
cell line (167) 167
neuropeptides - metabolism (166) 166
cyclic amp - metabolism (164) 164
health aspects (164) 164
molecular-cloning (163) 163
rat (161) 161
adult (157) 157
central-nervous-system (157) 157
hormones (157) 157
gene-related peptide (154) 154
biology (151) 151
rats, wistar (148) 148
science (146) 146
gene expression regulation (144) 144
ligands (144) 144
receptors, pituitary adenylate cyclase-activating polypeptide, type i (143) 143
pituitary adenylate cyclase-activating polypeptide - metabolism (142) 142
receptors, vasoactive intestinal peptide - metabolism (142) 142
polypeptides (141) 141
receptors, pituitary hormone - genetics (140) 140
receptors, vasoactive intestinal polypeptide, type i (139) 139
tissue distribution (139) 139
endocrine system (134) 134
signal transduction - physiology (134) 134
genes (133) 133
pharmacology (131) 131
vasoactive intestinal peptides (131) 131
functional expression (130) 130
peptide (130) 130
medicine & public health (127) 127
neuropeptides - pharmacology (127) 127
in situ hybridization (126) 126
dose-response relationship, drug (125) 125
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (139) 139
UTL at Downsview - May be requested (7) 7
UofT at Mississauga - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Online Resources - Online (5) 5
UofT at Scarborough - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3329) 3329
Spanish (11) 11
Japanese (4) 4
German (3) 3
French (2) 2
Arabic (1) 1
Chinese (1) 1
Hebrew (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Leukocyte Biology, ISSN 0741-5400, 12/2016, Volume 100, Issue 6, pp. 1385 - 1393
VIP neuropeptide counterbalances the pro‐inflammatory profile of in vitro GM‐CSF‐polarized macrophages in favor of anti‐inflammatory function. This study... 
granulocyte | anti‐inflammatory | human monocyte | inflammation | rheumatoid arthritis | Inflammation | Human monocyte | Anti-inflammatory | Rheumatoid arthritis | Granulocyte | RHEUMATOID-ARTHRITIS | ACTIVATION | IMMUNE CELLS | VASOACTIVE-INTESTINAL-PEPTIDE | ARTHRITIS SYNOVIAL FIBROBLASTS | INFLAMMATORY DISEASES | RECEPTOR EXPRESSION | IMMUNOLOGY | CELL BIOLOGY | AUTOIMMUNE | IN-VIVO | anti-inflammatory | HEMATOLOGY | T-CELLS | Up-Regulation | Humans | Receptors, Vasoactive Intestinal Polypeptide, Type I - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - biosynthesis | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Receptors, Vasoactive Intestinal Peptide, Type II - physiology | RNA, Messenger - biosynthesis | Receptors, Vasoactive Intestinal Peptide, Type II - drug effects | Vasoactive Intestinal Peptide - pharmacology | Macrophage Colony-Stimulating Factor - pharmacology | Synovial Fluid - cytology | Cyclic AMP - metabolism | Cytokines - genetics | Receptors, Vasoactive Intestinal Polypeptide, Type I - biosynthesis | Cells, Cultured | Granulocyte-Macrophage Colony-Stimulating Factor - pharmacology | Receptors, Vasoactive Intestinal Polypeptide, Type I - physiology | Immunophenotyping | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Arthritis, Rheumatoid - pathology | Gene Expression Regulation - drug effects | Macrophages - metabolism | Macrophages - drug effects | Macrophage Activation - drug effects | Cytokines - biosynthesis | Index Medicus
Journal Article
Cephalalgia, ISSN 0333-1024, 1/2011, Volume 31, Issue 2, pp. 181 - 189
Objective: We pharmacologically characterized pituitary adenylate cyclase–activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC1,... 
PAC1 | PACAP38 | VPAC1 | VIP | VPAC2 | CYCLASE-ACTIVATING POLYPEPTIDE | RAT | IMMUNOHISTOCHEMICAL LOCALIZATION | MIGRAINE | NEUROSCIENCES | PEPTIDE | CLINICAL NEUROLOGY | PAC | VPAC | MESSENGER-RNA | HEADACHE | CEREBRAL-ARTERIES | HEALTHY-VOLUNTEERS | EXPRESSION | Pituitary Adenylate Cyclase-Activating Polypeptide - antagonists & inhibitors | Receptors, Vasoactive Intestinal Polypeptide, Type I - antagonists & inhibitors | Gene Expression - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - agonists | Humans | Middle Aged | Male | Peptide Fragments - pharmacology | Receptors, Vasoactive Intestinal Peptide - genetics | RNA, Messenger - metabolism | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Meningeal Arteries - physiology | Vasoactive Intestinal Peptide - pharmacology | Receptors, Vasoactive Intestinal Polypeptide, Type I - agonists | Gene Expression - physiology | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Migraine Disorders - physiopathology | Adult | Female | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - agonists | Vasodilation - physiology | Coronary Vessels - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - antagonists & inhibitors | Vasodilator Agents - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | Coronary Vessels - physiology | Pituitary Adenylate Cyclase-Activating Polypeptide - adverse effects | Meningeal Arteries - drug effects | Migraine Disorders - drug therapy | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Aged | Receptors, Vasoactive Intestinal Peptide - antagonists & inhibitors | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Vasodilation - drug effects | Receptors, Vasoactive Intestinal Peptide - agonists | Vasoactive Intestinal Peptide - analogs & derivatives | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - antagonists & inhibitors | Index Medicus
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 12/2015, Volume 35, Issue 50, pp. 16463 - 16478
Vasoactive intestinal peptide (VIP) mediates a broad range of biological responses by activating two related receptors, VIP receptor 1 and 2 (VIPR1 and VIPR2).... 
Neuroprotection | Adaptive immunity | Inflammation | VPAC | VIP | Parkinson’s disease | CYCLASE-ACTIVATING POLYPEPTIDE | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | ACTION IN-VIVO | Parkinson's disease | VASOACTIVE-INTESTINAL-PEPTIDE | NEUROSCIENCES | adaptive immunity | ALPHA-HELIX MIMICRY | EXPERIMENTAL ARTHRITIS | inflammation | neuroprotection | MOUSE MODEL | REGULATORY T-CELLS | ADENYLATE-CYCLASE | PARKINSONS-DISEASE | Immunohistochemistry | Neuroprotective Agents - therapeutic use | Tyrosine 3-Monooxygenase - metabolism | Cricetulus | Substantia Nigra - pathology | Humans | MPTP Poisoning - physiopathology | Receptors, Vasoactive Intestinal Polypeptide, Type I - drug effects | Spleen - drug effects | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Microglia - immunology | Receptors, Vasoactive Intestinal Peptide, Type II - drug effects | Dopaminergic Neurons - drug effects | MPTP Poisoning - immunology | CHO Cells | Substantia Nigra - enzymology | Cell Line | Cricetinae | Dopaminergic Neurons - immunology | Cytokines - metabolism | Microglia - drug effects | Mice, Inbred C57BL | Oligopeptides - pharmacokinetics | CD4-Positive T-Lymphocytes - metabolism | Spleen - cytology | MPTP Poisoning - drug therapy | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Animals | Mice | Oligopeptides - pharmacology | Receptors, Vasoactive Intestinal Peptide - agonists | Index Medicus
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 06/2017, Volume 292, Issue 24, pp. 9865 - 9881
The glucagon receptor (GCGR) belongs to the secretin-like (class B) family of G protein-coupled receptors (GPCRs) and is activated by the peptide hormone... 
BETA ADRENERGIC-RECEPTOR | LIGAND-BINDING | GLUCAGON RECEPTOR | IONIC LOCK | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CROSS-LINKING STRATEGY | METAPHYSEAL CHONDRODYSPLASIA | BETA-ADRENERGIC RECEPTOR | PEPTIDE | MUSCARINIC ACETYLCHOLINE-RECEPTOR | Receptor, Parathyroid Hormone, Type 1 - chemistry | Receptors, Corticotropin-Releasing Hormone - metabolism | Receptor, Parathyroid Hormone, Type 1 - metabolism | Humans | Receptors, Corticotropin-Releasing Hormone - agonists | Receptors, Corticotropin-Releasing Hormone - genetics | Receptor, Parathyroid Hormone, Type 1 - agonists | Recombinant Fusion Proteins - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - agonists | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - chemistry | Conserved Sequence | Protein Interaction Domains and Motifs | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - agonists | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Protein Stability | Binding Sites | Peptide Fragments - genetics | Second Messenger Systems | Receptors, Glucagon - agonists | Receptors, Glucagon - genetics | Receptors, Vasoactive Intestinal Polypeptide, Type I - chemistry | Recombinant Proteins - metabolism | Amino Acid Sequence | Cell Line | Peptide Fragments - metabolism | Mutagenesis, Site-Directed | Models, Molecular | Receptors, Glucagon - metabolism | Recombinant Proteins - chemistry | Recombinant Fusion Proteins - chemistry | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Peptide Fragments - chemistry | Peptide Fragments - agonists | Receptors, Glucagon - chemistry | Hydrophobic and Hydrophilic Interactions | Receptor, Parathyroid Hormone, Type 1 - genetics | Ligands | Protein Conformation | Structural Homology, Protein | Mutation | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Receptors, Corticotropin-Releasing Hormone - chemistry | Amino Acid Substitution | Index Medicus | Editors' Picks | 7-helix receptor | G protein-coupled receptor (GPCR) | parathyroid hormone | glucagon | arrestin
Journal Article
Peptides, ISSN 0196-9781, 09/2012, Volume 37, Issue 1, pp. 32 - 39
► Streptozotocin (STZ) treatment diminishes retinal expression of PACAP and VIP. ► STZ-induced diabetes decreases Bcl2 and increases p53 expression in retina.... 
Diabetic retinopathy | Retina | PACAP | Rat | VIP | Streptozotocin | SIGNALING PATHWAYS | NEURAL APOPTOSIS | PROTEIN-KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | I RECEPTOR | CELL-DEATH | MESSENGER-RNA | POLYPEPTIDE PACAP | PHARMACOLOGY & PHARMACY | INDUCED NEUROTOXICITY | UP-REGULATION | ENDOTHELIAL GROWTH-FACTOR | Vasoactive Intestinal Peptide - metabolism | Retina - metabolism | Gene Expression - drug effects | Intravitreal Injections | Streptozocin | Male | DNA Primers - genetics | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Tumor Suppressor Protein p53 - genetics | Diabetes Mellitus, Experimental - blood | Proto-Oncogene Proteins c-bcl-2 - metabolism | Base Sequence | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Diabetes Mellitus, Experimental - metabolism | Receptors, Vasoactive Intestinal Peptide, Type II - metabolism | Tumor Suppressor Protein p53 - metabolism | Blood Glucose | Rats, Sprague-Dawley | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Animals | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Pituitary Adenylate Cyclase-Activating Polypeptide - administration & dosage | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Ophthalmology | Vasoactive intestinal peptides | Tumor proteins | Index Medicus
Journal Article
American Journal of Pathology, ISSN 0002-9440, 2010, Volume 177, Issue 5, pp. 2563 - 2575
Journal Article
Brain Research, ISSN 0006-8993, 2008, Volume 1241, pp. 29 - 35
Abstract Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) are structurally endogenous peptides showing rich... 
Neurology | Schwannoma cells | PACAP | VIP | Apoptosis | SURVIVAL | CYCLASE-ACTIVATING POLYPEPTIDE | HUMAN BRAIN-TUMORS | VASOACTIVE-INTESTINAL-PEPTIDE | HUMAN PITUITARY-ADENOMAS | SPINAL-CORD | NEUROSCIENCES | MESSENGER-RNA | RAT-BRAIN | RECEPTORS | EXPRESSION | Vasoactive Intestinal Peptide - metabolism | Apoptosis - drug effects | Nerve Growth Factors - metabolism | RNA, Messenger - metabolism | Schwann Cells - cytology | Dose-Response Relationship, Drug | Nerve Growth Factors - pharmacology | Proto-Oncogene Proteins c-bcl-2 - metabolism | Vasoactive Intestinal Peptide - pharmacology | Receptors, Vasoactive Intestinal Polypeptide, Type I - agonists | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - agonists | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Cell Survival - physiology | bcl-2-Associated X Protein - genetics | RNA, Messenger - drug effects | Schwann Cells - drug effects | Cell Survival - drug effects | Pituitary Adenylate Cyclase-Activating Polypeptide - genetics | bcl-2-Associated X Protein - metabolism | Rats | Schwann Cells - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | bcl-2-Associated X Protein - drug effects | Animals | Pituitary Adenylate Cyclase-Activating Polypeptide - metabolism | Proto-Oncogene Proteins c-bcl-2 - drug effects | Cell Line, Tumor | Apoptosis - physiology | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Vasoactive Intestinal Peptide - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Culture Media, Serum-Free - toxicity | Prevention | Adenylate cyclase | Polypeptides | Analysis | Vasoactive intestinal peptides | Gene expression | Index Medicus
Journal Article
American Journal of Physiology - Gastrointestinal and Liver Physiology, ISSN 0193-1857, 2017, Volume 313, Issue 1, pp. G16 - G25
Journal Article
Peptides, ISSN 0196-9781, 04/2016, Volume 78, pp. 30 - 41
Neuroblastoma (NB) is a pediatric cancer. New therapies for high-risk NB aim to induce cell differentiation and to inhibit MYCN and ALK signaling in NB. The... 
ALK | AKT | MYCN | Differentiation | Invasion | PKA | CANCER-CELLS | NERVOUS-SYSTEM | VASOACTIVE-INTESTINAL-PEPTIDE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TUMORS | NEUROPEPTIDES | VPAC RECEPTORS | PICA | IN-VITRO | ENDOCRINOLOGY & METABOLISM | PHARMACOLOGY & PHARMACY | GROWTH-FACTOR | Neurons - pathology | Humans | Pituitary Adenylate Cyclase-Activating Polypeptide - chemical synthesis | N-Myc Proto-Oncogene Protein - genetics | Vasoactive Intestinal Peptide - chemical synthesis | Structure-Activity Relationship | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Proto-Oncogene Proteins c-akt - genetics | Cyclic AMP-Dependent Protein Kinases - genetics | Vasoactive Intestinal Peptide - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Neurons - metabolism | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Neurons - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Cyclic AMP-Dependent Protein Kinases - metabolism | Signal Transduction | Receptors, Vasoactive Intestinal Peptide, Type II - metabolism | Organ Specificity | Receptor Protein-Tyrosine Kinases - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Cell Movement - drug effects | Receptor Protein-Tyrosine Kinases - genetics | Cell Differentiation - drug effects | N-Myc Proto-Oncogene Protein - metabolism | Cell Line, Tumor | Mutation | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Neuropeptides | Health aspects | Neuroblastoma | Index Medicus | Analogs | Mutations | Receptors | Polypeptides | Peptides | Genes | Cancer | Life Sciences
Journal Article
Journal of Molecular Neuroscience, ISSN 0895-8696, 11/2012, Volume 48, Issue 3, pp. 574 - 583
Migraine is a debilitating neurological disorder characterized by mild to severe headache that is often accompanied by aura and other neurological symptoms.... 
Neurochemistry | Neurology | Neurosciences | Biomedicine | Migraine | Calcitonin gene-related peptide (CGRP) | Proteomics | Neurotransmitter | Vascular smooth muscle | Cell Biology | Pituitary adenylate cyclase-activating polypeptide (PACAP) | GENE-RELATED PEPTIDE | VASOACTIVE-INTESTINAL-PEPTIDE | RAT | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEUROSCIENCES | RESPONSES | HEADACHE | CEREBRAL-ARTERIES | HEALTHY-VOLUNTEERS | RECEPTORS | VIP | EXPRESSION | Meningeal Arteries - metabolism | Humans | Male | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - physiology | Receptors, Vasoactive Intestinal Peptide, Type II - biosynthesis | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | RNA, Messenger - biosynthesis | Vasoactive Intestinal Peptide - pharmacology | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Migraine Disorders - physiopathology | Nerve Tissue Proteins - biosynthesis | Nerve Tissue Proteins - physiology | RNA, Messenger - genetics | Receptors, Vasoactive Intestinal Polypeptide, Type I - biosynthesis | Rats | Meningeal Arteries - drug effects | Organ Specificity | Nerve Tissue Proteins - genetics | Pressure | Rats, Sprague-Dawley | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Cerebellum - blood supply | Gene Expression Regulation - drug effects | Animals | Protein Isoforms - biosynthesis | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Vasodilation - drug effects | In Vitro Techniques | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - biosynthesis | Protein Isoforms - genetics | Index Medicus | Cerebellum | Brain | Headache | PAC1 protein | Nervous system | Arteries | Vasodilation | Fibers | Pituitary adenylate cyclase-activating polypeptide | Polymerase chain reaction | Autonomic nervous system | Etiology | Pituitary adenylate cyclase-activating polypeptide receptors | Parasympathetic nervous system
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, pp. e91541 - e91541
Pituitary adenylate cyclase activating polypeptide (PACAP) is an important neurotrophic factor influencing differentiation of neuronal elements and exerting... 
INDUCED CELL-DEATH | PROGENITOR CELLS | CYCLIC-AMP | IN-VITRO | CARTILAGE DIFFERENTIATION | CORTICAL-NEURONS | MULTIDISCIPLINARY SCIENCES | CHICKEN PINEALOCYTES | STRESS-INDUCED APOPTOSIS | EXTRACELLULAR DOMAIN | HYDROGEN-PEROXIDE | Chondrocytes - cytology | Cell Proliferation | Oxidative Stress | Chondrogenesis - genetics | Cyclosporine - pharmacology | Limb Buds - cytology | Pituitary Adenylate Cyclase-Activating Polypeptide - chemical synthesis | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Chondrocytes - drug effects | Calcineurin - genetics | Peptides - chemical synthesis | Gene Expression Regulation, Developmental | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacology | Cell Differentiation | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - metabolism | Receptors, Vasoactive Intestinal Polypeptide, Type I - metabolism | Chondrocytes - metabolism | SOX9 Transcription Factor - metabolism | Calcineurin Inhibitors - pharmacology | Signal Transduction | Receptors, Vasoactive Intestinal Peptide, Type II - metabolism | Hydrogen Peroxide - pharmacology | Chick Embryo | Receptors, Vasoactive Intestinal Polypeptide, Type I - genetics | Peptides - pharmacology | Animals | Limb Buds - metabolism | Limb Buds - growth & development | Primary Cell Culture | Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I - genetics | Limb Buds - drug effects | SOX9 Transcription Factor - genetics | Calcineurin - metabolism | Physiological aspects | Calcium-binding proteins | Phosphatases | Cell proliferation | Oxidative stress | Phosphorylation | Transcription factors | PAC1 protein | Adrenal glands | Downstream effects | Cyclosporins | Calcineurin | Sox9 protein | Central nervous system | Neuropeptides | Kinases | Tissues | Limb buds | Proteins | Cartilage | Receptors | Embryology | Rodents | Calcium-binding protein | Chondrogenesis | Calmodulin | Polypeptides | Pulmonary arteries | Cultures | Histology | Cartilage (articular) | Pharmacology | Inflammation | Gene expression | Medicine | Pituitary adenylate cyclase-activating polypeptide | Regeneration | Signaling | Collagen | Chondrocytes | Protein phosphatase | Differentiation | Apoptosis | Index Medicus
Journal Article